Clinical Trial Update: Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing daptomycin to vancomycin for MRSA bacteremia in nosocomial/healthcare-associated infections was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthcare-associated Infection
• Methicillin-resistant Staphylococcus Aureus Bacteremia
• Nosocomial Infection

Drugs mentioned

• Cubicin (daptomycin)
• Vancocin (vancomycin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Nosocomial Infection, Healthcare-associated Infection | Phase 3 | Status: TERMINATED